Contact Molecules for Homologous Proteins | ||||
[Full Bars] |
[SiteTable] |
|
[Back to Search Page] |
[Back to HOMCOS] |
[SupCon3D] |
[help] |
seq_id(%): [0] [30] [40] [50] [60] [70] [80] [90] [95] [100] | [show] [download] [help] |
PID | QueryLength | Homolgous Sequence in PDB | UniProt Query | TITLE |
277857 | 805 | 500 | Q9BYF1(ACE2_HUMAN) | RecName: Full=Angiotensin-converting enzyme 2; EC=3.4.17.23 ;AltName: Full=Angiotensin-converting enzyme homolog ; Short=ACEH ;AltName: Full=Angiotensin-converting enzyme-related carboxypeptidase ; Short=ACE-related carboxypeptidase; EC=3.4.17.- ;AltName: Full=Metalloprotease MPROT15 ;Contains: RecName: Full=Processed angiotensin-converting enzyme 2 ;Flags: Precursor; |
QUERYSEQ |
MSSSSWLLLSLVAVTAAQSTIEEQAKTFLDKFNHEAEDLFYQSSLASWNYNTNITEENVQNMNNAGDKWSAFLKEQSTLAQMYPLQEIQNLTVKLQLQALQQNGSSVLSEDKSKRLNTILNTMSTIYSTGKVCNPDNPQECLLLEPGLNE IMANSLDYNERLWAWESWRSEVGKQLRPLYEEYVVLKNEMARANHYEDYGDYWRGDYEVNGVDGYDYSRGQLIEDVEHTFEEIKPLYEHLHAYVRAKLMNAYPSYISPIGCLPAHLLGDMWGRFWTNLYSLTVPFGQKPNIDVTDAMVDQ AWDAQRIFKEAEKFFVSVGLPNMTQGFWENSMLTDPGNVQKAVCHPTAWDLGKGDFRILMCTKVTMDDFLTAHHEMGHIQYDMAYAAQPFLLRNGANEGFHEAVGEIMSLSAATPKHLKSIGLLSPDFQEDNETEINFLLKQALTIVGTL PFTYMLEKWRWMVFKGEIPKDQWMKKWWEMKREIVGVVEPVPHDETYCDPASLFHVSNDYSFIRYYTRTLYQFQFQEALCQAAKHEGPLHKCDISNSTEAGQKLFNMLRLGKSEPWTLALENVVGAKNMNVRPLLNYFEPLFTWLKDQNK NSFVGWSTDWSPYADQSIKVRISLKSALGDKAYEWNDNEMYLFRSSVAYAMRQYFLKVKNQMILFGEEDVRVANLKPRISFNFFVTAPKNVSDIIPRTEVEKAIRMSRSRINDAFRLNDNSLEFLGIQPTLGPPNQPPVSIWLIVFGVVM GVIVVGIVILIFTGIRDRKKKNKARSGENPYASIDISKGENNPGFQNTDDVQTSF |
805 | region | name | description |
1-17 | SIGNAL | ||
18-805 | CHAIN | /note="Angiotensin-converting enzyme 2" /id="PRO_0000028570" | |
18-708 | CHAIN | /note="Processed angiotensin-converting enzyme 2" /id="PRO_0000292268" | |
18-740 | TOPO_DOM | /note="Extracellular" | |
741-761 | TRANSMEM | /note="Helical" | |
762-805 | TOPO_DOM | /note="Cytoplasmic" | |
19-607 | DOMAIN | /note="Peptidase M2" | |
614-805 | DOMAIN | /note="Collectrin-like" | |
30-41 | REGION | /note="Interaction with SARS-CoV spike glycoprotein" | |
82-84 | REGION | /note="Interaction with SARS-CoV spike glycoprotein" | |
353-357 | REGION | /note="Interaction with SARS-CoV spike glycoprotein" | |
652-659 | REGION | /note="Essential for cleavage by ADAM17" | |
697-716 | REGION | /note="Essential for cleavage by TMPRSS11D and TMPRSS2" | |
772-805 | REGION | /note="Disordered" | |
785-805 | COMPBIAS | /note="Polar residues" | |
375-375 | ACT_SITE | /note="Proton acceptor" ECO:0000305|PubMed:14754895, ECO:0000305|PubMed:27217402" | |
505-505 | ACT_SITE | /note="Proton donor" ECO:0000305|PubMed:14754895" | |
169-169 | BINDING | /ligand="chloride" /ligand_id="ChEBI:CHEBI:17996" ECO:0000269|PubMed:14754895, ECO:0000305|PubMed:19021774" | |
273-273 | BINDING | /ligand="substrate" | |
345-346 | BINDING | /ligand="substrate" | |
374-374 | BINDING | /ligand="Zn(2+)" /ligand_id="ChEBI:CHEBI:29105" /ligand_note="catalytic" ECO:0000269|PubMed:14754895" | |
378-378 | BINDING | /ligand="Zn(2+)" /ligand_id="ChEBI:CHEBI:29105" /ligand_note="catalytic" ECO:0000269|PubMed:14754895" | |
402-402 | BINDING | /ligand="Zn(2+)" /ligand_id="ChEBI:CHEBI:29105" /ligand_note="catalytic" ECO:0000269|PubMed:14754895" | |
477-477 | BINDING | /ligand="chloride" /ligand_id="ChEBI:CHEBI:17996" ECO:0000269|PubMed:14754895, ECO:0000305|PubMed:19021774" | |
481-481 | BINDING | /ligand="chloride" /ligand_id="ChEBI:CHEBI:17996" ECO:0000269|PubMed:14754895, ECO:0000305|PubMed:19021774" | |
515-515 | BINDING | /ligand="substrate" | |
1-805 | DISORDER | predicted by DISOPRED |
MONOMER | |||||||
805 | |||||||
pdb_id | a1 | identity[%]2 | description | ||||
7v61 | B | 100.0 | ACE2_HUMAN Angiotensin-converting enzyme 2 | ||||
1.a1:asym_id for the homologue. 2.identity[%]2:sequence identity between the query and the homologue. |
HETERO | |||||||
805 | pdb_id | contact mol | homologue | ||||
a3 | description | a4 | identity[%]5 | Ncon6 | description | ||
1r4l[1] | B | disordered segment of collectrin homology domain[6.. | A | 100.0 /100.0 |
2 /2 |
ACE2_HUMAN angiotensin I converting enzyme 2 | |
1r4l[1] | C | disordered segment of collectrin homology domain[2.. | A | 100.0 /100.0 |
2 /2 |
ACE2_HUMAN angiotensin I converting enzyme 2 | |
1r4l[1] | E | disordered segment of collectrin homology domain[1.. | A | 100.0 /100.0 |
1 /1 |
ACE2_HUMAN angiotensin I converting enzyme 2 | |
3kbh[4] | B | SPIKE_CVHNL Spike glycoprotein[110 aa] | A | 100.0 /100.0 |
17 /17 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
6acj[1] | C | SPIKE_CVHSA Spike glycoprotein[1057 aa] | D | 100.0 /100.0 |
20 /20 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
6m17[8] | A | S6A19_HUMAN Sodium-dependent neutral amino acid transporter B(.. | B | 100.0 /100.0 |
24 /24 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
8wby[2] | A | S6A19_HUMAN Sodium-dependent neutral amino acid transporter B(.. | B | 100.0 /100.0 |
17 /17 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
6m17[3] | C | SPIKE_SARS2 Spike protein S1[183 aa] | B | 100.0 /100.0 |
17 /17 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7c8d[18] | B | SPIKE_SARS2 Spike protein S1[195 aa] | A | 77.8 /86.1 |
18 /18 |
ACE2_FELCA Angiotensin-converting enzyme 2 | |
7l7f[3] | B | SPIKE_SARS2 SPIKE_SARS2 M1E1E4_9HIV1 Spike glycoprotein, Envelope glycoprotein fusion[1.. | A | 100.0 /100.0 |
9 /9 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7vx4[1] | B | SPIKE_SARS2 Spike glycoprotein[194 aa] | A | 100.0 /100.0 |
19 /19 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7a92[1] | B | SPIKE_SARS2 Spike glycoprotein[643 aa] | A | 100.0 /100.0 |
18 /18 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7a95[35] | A | SPIKE_SARS2 Spike glycoprotein[1069 aa] | D | 100.0 /100.0 |
18 /18 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7dx5[4] | A | SPIKE_SARS2 Spike glycoprotein[1007 aa] | D | 100.0 /100.0 |
14 /14 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7kne[22] | C | SPIKE_SARS2 Spike glycoprotein[1029 aa] | D | 100.0 /100.0 |
18 /18 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
8vkl[1] | C | SPIKE_SARS2 Spike glycoprotein[1047 aa] | D | 100.0 /84.4 |
3 /3 |
ACE2_MOUSE Angiotensin-converting enzyme 2 | |
7e7e[2] | B | h11B11-Fab[208 aa] | A | 100.0 /100.0 |
6 /6 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
7e7e[1] | C | h11B11-Fab[210 aa] | A | 100.0 /100.0 |
2 /2 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
7e7e[1] | F | h11B11-Fab[210 aa] | D | 100.0 /100.0 |
5 /5 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
7t9l[16] | A | SPIKE_SARS2 Spike glycoprotein[201 aa] | B | 100.0 /100.0 |
17 /17 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
7wpb[11] | A | SPIKE_SARS2 Spike glycoprotein[198 aa] | B | 100.0 /100.0 |
19 /19 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7y75[2] | C | SPIKE_SARS2 Spike protein S1[198 aa] | B | 100.0 /100.0 |
16 /16 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7v61[2] | C | 3E8[223 aa] | B | 100.0 /100.0 |
12 /12 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7v61[2] | D | 3E8[214 aa] | B | 100.0 /100.0 |
3 /3 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7xbf[2] | B | RshSTT182/200 coronavirus receptor binding domain .. | A | 100.0 /100.0 |
17 /17 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
8bn1[2] | D | ALA-CYS-VAL-ARG-SER-4PH-CYS-SER-SER-LEU-LEU-PRO-AR.. | A | 100.0 /100.0 |
33 /33 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
8byj[2] | D | ALA-CYS-VAL-ARG-SER-HIS-CYS-SER-SER-LEU-LEU-PRO-AR.. | A | 100.0 /100.0 |
30 /30 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
8fxb[1] | D | SPIKE_SARS2 Spike protein S1[162 aa] | C | 100.0 /100.0 |
16 /16 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
8toq[1] | B | Peptide 1[13 aa] | A | 100.0 /100.0 |
20 /20 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
8tot[2] | C | Cyclic peptide 2[15 aa] | A | 100.0 /100.0 |
32 /32 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
8we4[1] | C | S304 Fab Heavy Chain[118 aa] | A | 100.0 /100.0 |
1 /1 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
8wlz[2] | A | U5WI05_SARS A0A346FJN8_BPT6 Spike glycoprotein,Fibritin[1068 aa] | D | 100.0 /100.0 |
22 /22 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
7y75[8] | A | S6A20_HUMAN Sodium- and chloride-dependent transporter XTRP3[5.. | B | 100.0 /100.0 |
19 /19 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
8wm3[2] | A | S6A20_HUMAN Sodium- and chloride-dependent transporter XTRP3[5.. | B | 100.0 /99.9 |
15 /15 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
8uze[2] | C | Receptor binding domain[188 aa] | A | 66.7 /95.8 |
15 /15 |
Angiotensin-converting enzyme 2 | |
8uzf[2] | C | Receptor binding domain[188 aa] | A | 58.8 /95.8 |
17 /17 |
Angiotensin-converting enzyme 2 | |
7drv[3] | B | A0A6B9WHD3_SARS Spike glycoprotein[195 aa] | A | 100.0 /100.0 |
16 /16 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7p8j[2] | B | A0A6B9WHD3_SARS Spike glycoprotein[193 aa] | A | 100.0 /100.0 |
16 /16 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
2ajf[8] | C | SPIKE_CVHSA SARS-coronavirus spike protein[174 aa] | A | 100.0 /100.0 |
20 /20 |
ACE2_HUMAN Angiotensin-converting enzyme-Related Carboxypepti.. | |
7wsf[2] | B | SPIKE_SARS Spike protein S1[186 aa] | A | 80.0 /83.4 |
20 /20 |
A0A452CBT6_BALAS Angiotensin-converting enzyme | |
7wpo[1] | B | U5NJG5_MERS Spike glycoprotein[187 aa] | A | 61.5 /78.2 |
13 /13 |
A0A7J7V5I6_PIPKU Angiotensin-converting enzyme | |
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue. | |||||||
COMPOUND | |||||||
805 | pdb_id | contact mol | homologue | ||||
a3 | description | a4 | identity[%]5 | Ncon6 | description | ||
1r4l[47] | F |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
A | 100.0 /100.0 |
3 /3 |
ACE2_HUMAN angiotensin I converting enzyme 2 | |
1r4l[8] | G |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
A | 100.0 /100.0 |
3 /3 |
ACE2_HUMAN angiotensin I converting enzyme 2 | |
2ajf[86] | G |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
A | 100.0 /100.0 |
4 /4 |
ACE2_HUMAN Angiotensin-converting enzyme-Related Carboxypepti.. | |
2ajf[54] | H |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
A | 100.0 /100.0 |
4 /4 |
ACE2_HUMAN Angiotensin-converting enzyme-Related Carboxypepti.. | |
2ajf[39] | I |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
A | 100.0 /100.0 |
3 /3 |
ACE2_HUMAN Angiotensin-converting enzyme-Related Carboxypepti.. | |
3kbh[46] | I |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
A | 100.0 /100.0 |
3 /3 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7a92[16] | D |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
A | 100.0 /100.0 |
3 /3 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7a92[2] | H |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
A | 100.0 /100.0 |
3 /3 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7ekg[35] | G |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
A | 100.0 /100.0 |
2 /2 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7p19[2] | G |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
A | 100.0 /100.0 |
2 /2 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
7r0z[9] | H |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
A | 100.0 /100.0 |
3 /3 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7v89[8] | IB |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
D | 100.0 /100.0 |
3 /3 |
ACE2_HUMAN Angiotensin-converting enzyme 2,Angiotensin-conver.. | |
7vx4[1] | G |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
A | 100.0 /100.0 |
4 /4 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7wa3[1] | E |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
A | 75.0 /84.1 |
4 /4 |
A0A7T0Q2W2_NEOVI Angiotensin-converting enzyme | |
7wpo[1] | I |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
A | 25.0 /78.2 |
4 /4 |
A0A7J7V5I6_PIPKU Angiotensin-converting enzyme | |
7wpo[1] | J |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
A | 80.0 /78.2 |
5 /5 |
A0A7J7V5I6_PIPKU Angiotensin-converting enzyme | |
7xo4[1] | QA |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
D | 100.0 /84.6 |
3 /3 |
ACE2_MOUSE Angiotensin-converting enzyme 2 | |
8p2y[6] | K |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
A | 100.0 /100.0 |
3 /3 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
8p2y[6] | N |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
A | 100.0 /100.0 |
3 /3 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
8p30[2] | U |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
A | 100.0 /100.0 |
1 /1 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
1r4l[1] | J |
XX5
(S,S)-2-{1-CARBOXY-2-[3-(3,5-DICHLORO-BENZYL)-3H-I.. |
A | 100.0 /100.0 |
16 /16 |
ACE2_HUMAN angiotensin I converting enzyme 2 | |
3d0g[2] | E |
NDG
2-acetamido-2-deoxy-alpha-D-glucopyranose[15 atoms.. |
A | 100.0 /98.5 |
3 /3 |
ACE2_PAGLA ACE2_HUMAN Angiotensin-converting enzyme 2 | |
3d0g[1] | I |
NDG
2-acetamido-2-deoxy-alpha-D-glucopyranose[15 atoms.. |
B | 100.0 /98.5 |
1 /1 |
ACE2_PAGLA ACE2_HUMAN Angiotensin-converting enzyme 2 | |
3d0g[1] | J |
NDG
2-acetamido-2-deoxy-alpha-D-glucopyranose[15 atoms.. |
B | 100.0 /98.5 |
3 /3 |
ACE2_PAGLA ACE2_HUMAN Angiotensin-converting enzyme 2 | |
8p2y[6] | J |
NDG
2-acetamido-2-deoxy-alpha-D-glucopyranose[14 atoms.. |
A | 100.0 /100.0 |
3 /3 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
6m18[4] | W |
3PH
1,2-DIACYL-GLYCEROL-3-SN-PHOSPHATE[48 atoms] |
B | 100.0 /100.0 |
1 /1 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
8bn1[4] | I |
LFI
1-[3,5-bis(3-bromanylpropanoyl)-1,3,5-triazinan-1-.. |
A | 100.0 /100.0 |
1 /1 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue. | |||||||
METAL | |||||||
805 | pdb_id | contact mol | homologue | ||||
a3 | description | a4 | identity[%]5 | Ncon6 | description | ||
1r4l[17] | I |
ZN
ZINC ION[1 atoms] |
A | 100.0 /100.0 |
3 /3 |
ACE2_HUMAN angiotensin I converting enzyme 2 | |
2ajf[36] | J |
ZN
ZINC ION[1 atoms] |
A | 100.0 /100.0 |
4 /4 |
ACE2_HUMAN Angiotensin-converting enzyme-Related Carboxypepti.. | |
6m17[8] | CA |
ZN
ZINC ION[1 atoms] |
B | 100.0 /100.0 |
4 /4 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7a92[2] | I |
ZN
ZINC ION[1 atoms] |
A | 100.0 /100.0 |
3 /3 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7c8d[3] | C |
ZN
ZINC ION[1 atoms] |
A | 100.0 /86.1 |
4 /4 |
ACE2_FELCA Angiotensin-converting enzyme 2 | |
7dhx[19] | E |
ZN
ZINC ION[1 atoms] |
A | 100.0 /85.5 |
4 /4 |
pangolin ACE2 | |
7wsf[1] | C |
ZN
ZINC ION[1 atoms] |
A | 100.0 /83.4 |
4 /4 |
A0A452CBT6_BALAS Angiotensin-converting enzyme | |
8bn1[1] | F |
ZN
ZINC ION[1 atoms] |
A | 100.0 /100.0 |
2 /2 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
8byj[1] | G |
NA
SODIUM ION[1 atoms] |
B | 100.0 /100.0 |
4 /4 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
8uze[1] | P |
NA
SODIUM ION[1 atoms] |
A | 100.0 /95.8 |
4 /4 |
Angiotensin-converting enzyme 2 | |
1r4l[2] | H |
CL
CHLORIDE ION[1 atoms] |
A | 100.0 /100.0 |
4 /4 |
ACE2_HUMAN angiotensin I converting enzyme 2 | |
2ajf[13] | K |
CL
CHLORIDE ION[1 atoms] |
A | 100.0 /100.0 |
4 /4 |
ACE2_HUMAN Angiotensin-converting enzyme-Related Carboxypepti.. | |
7tn0[1] | CA |
CL
CHLORIDE ION[1 atoms] |
E | 100.0 /100.0 |
2 /2 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7tn0[3] | DA |
CL
CHLORIDE ION[1 atoms] |
E | 100.0 /100.0 |
3 /3 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7wpa[1] | IA |
CL
CHLORIDE ION[1 atoms] |
D | 100.0 /100.0 |
3 /3 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
8toq[3] | G |
CL
CHLORIDE ION[1 atoms] |
A | 100.0 /100.0 |
4 /4 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7xby[1] | D |
BR
BROMIDE ION[1 atoms] |
A | 100.0 /87.4 |
3 /3 |
F6V9L3_HORSE Angiotensin-converting enzyme | |
7xby[1] | E |
BR
BROMIDE ION[1 atoms] |
A | 100.0 /87.4 |
3 /3 |
F6V9L3_HORSE Angiotensin-converting enzyme | |
7xby[1] | F |
BR
BROMIDE ION[1 atoms] |
A | 100.0 /87.4 |
1 /1 |
F6V9L3_HORSE Angiotensin-converting enzyme | |
7xby[1] | G |
BR
BROMIDE ION[1 atoms] |
A | 100.0 /87.4 |
5 /5 |
F6V9L3_HORSE Angiotensin-converting enzyme | |
7xby[1] | H |
BR
BROMIDE ION[1 atoms] |
A | 100.0 /87.4 |
4 /4 |
F6V9L3_HORSE Angiotensin-converting enzyme | |
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue. | |||||||
OTHERPOLY | |||||||
805 | pdb_id | contact mol | homologue | ||||
a3 | description | a4 | identity[%]5 | Ncon6 | description | ||
2ajf[8] | E | beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. | A | 100.0 /100.0 |
2 /2 |
ACE2_HUMAN Angiotensin-converting enzyme-Related Carboxypepti.. | |
7p8j[2] | F | beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. | A | 100.0 /100.0 |
1 /1 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
7p8j[4] | G | beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. | A | 100.0 /100.0 |
1 /1 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
8if2[1] | C | beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. | A | 100.0 /100.0 |
5 /5 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
8if2[5] | F | beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. | A | 100.0 /100.0 |
4 /4 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
8p2y[4] | E | beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. | A | 100.0 /100.0 |
6 /6 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
8wdr[2] | F | beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. | C | 100.0 /100.0 |
3 /3 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
8y18[1] | D | beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. | A | 100.0 /100.0 |
1 /1 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
6m17[26] | H | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | B | 100.0 /100.0 |
3 /3 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
6m17[21] | I | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | B | 100.0 /100.0 |
2 /2 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
6m17[11] | J | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | B | 100.0 /100.0 |
3 /3 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
6m17[6] | K | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | B | 100.0 /100.0 |
3 /3 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
6m17[6] | M | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | B | 100.0 /100.0 |
5 /5 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7a92[20] | C | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | A | 100.0 /100.0 |
3 /3 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7drv[5] | E | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | A | 100.0 /100.0 |
3 /3 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7drv[2] | F | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | A | 100.0 /100.0 |
4 /4 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7dx5[18] | BA | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | D | 100.0 /100.0 |
3 /3 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7dx5[8] | CA | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | D | 100.0 /100.0 |
3 /3 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7dx5[22] | DA | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | D | 100.0 /100.0 |
2 /2 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7dx5[6] | Z | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | D | 100.0 /100.0 |
3 /3 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7kne[10] | J | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | D | 100.0 /100.0 |
2 /2 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7v61[2] | O | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | B | 100.0 /100.0 |
4 /4 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7v89[11] | TA | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | D | 100.0 /100.0 |
3 /3 |
ACE2_HUMAN Angiotensin-converting enzyme 2,Angiotensin-conver.. | |
7wpo[1] | E | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | A | 25.0 /78.2 |
4 /4 |
A0A7J7V5I6_PIPKU Angiotensin-converting enzyme | |
7y1z[12] | DA | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | D | 100.0 /100.0 |
5 /5 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
8if2[1] | E | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | A | 100.0 /100.0 |
2 /2 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
8p2y[6] | F | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | A | 100.0 /100.0 |
3 /3 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
8vkl[4] | X | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | D | 80.0 /84.4 |
5 /5 |
ACE2_MOUSE Angiotensin-converting enzyme 2 | |
8wby[4] | K | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | B | 100.0 /100.0 |
5 /5 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7wa3[1] | C | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al.. | B | 75.0 /84.1 |
4 /4 |
A0A7T0Q2W2_NEOVI Angiotensin-converting enzyme | |
7wpo[1] | F | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al.. | A | 66.7 /78.2 |
3 /3 |
A0A7J7V5I6_PIPKU Angiotensin-converting enzyme | |
8wdz[4] | D | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al.. | A | 100.0 /100.0 |
3 /3 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7wpo[1] | C | alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. | A | 80.0 /78.2 |
5 /5 |
A0A7J7V5I6_PIPKU Angiotensin-converting enzyme | |
8jyn[5] | N | alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. | D | 100.0 /100.0 |
10 /10 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
8if2[1] | D | alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. | A | 100.0 /100.0 |
5 /5 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
8p30[2] | E | alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. | A | 100.0 /100.0 |
12 /12 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue. | |||||||
HOMO | |||||||
805 | pdb_id | contact mol | homologue | ||||
a3 | description | a4 | identity[%]5 | Ncon6 | description | ||
3d0g[1] | B | ACE2_PAGLA ACE2_HUMAN Angiotensin-converting enzyme 2[597 aa] | A | 100.0 /98.5 |
2 /2 |
ACE2_PAGLA ACE2_HUMAN Angiotensin-converting enzyme 2 | |
3d0g[1] | A | ACE2_PAGLA ACE2_HUMAN Angiotensin-converting enzyme 2[597 aa] | B | 100.0 /98.5 |
3 /3 |
ACE2_PAGLA ACE2_HUMAN Angiotensin-converting enzyme 2 | |
3kbh[4] | E | ACE2_HUMAN Angiotensin-converting enzyme 2[593 aa] | A | 100.0 /100.0 |
6 /6 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
6m17[10] | E | ACE2_HUMAN Angiotensin-converting enzyme 2[748 aa] | B | 100.0 /100.0 |
26 /26 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7l7f[6] | C | ACE2_HUMAN Angiotensin-converting enzyme 2[711 aa] | A | 100.0 /100.0 |
21 /21 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
8p2y[6] | B | ACE2_HUMAN Processed angiotensin-converting enzyme 2[749 aa] | A | 100.0 /100.0 |
28 /28 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue. | |||||||
PRECIPITANT | |||||||
805 | pdb_id | contact mol | homologue | ||||
a3 | description | a4 | identity[%]5 | Ncon6 | description | ||
7p19[2] | H |
EDO
1,2-ETHANEDIOL[4 atoms] |
A | 100.0 /100.0 |
3 /3 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
8uze[2] | J |
EDO
1,2-ETHANEDIOL[4 atoms] |
A | 100.0 /95.8 |
2 /2 |
Angiotensin-converting enzyme 2 | |
8uze[1] | L |
EDO
1,2-ETHANEDIOL[4 atoms] |
A | 100.0 /95.8 |
2 /2 |
Angiotensin-converting enzyme 2 | |
8uze[1] | M |
EDO
1,2-ETHANEDIOL[4 atoms] |
A | 100.0 /95.8 |
1 /1 |
Angiotensin-converting enzyme 2 | |
8uze[1] | O |
EDO
1,2-ETHANEDIOL[4 atoms] |
A | 100.0 /95.8 |
2 /2 |
Angiotensin-converting enzyme 2 | |
8uze[2] | S |
EDO
1,2-ETHANEDIOL[4 atoms] |
B | 100.0 /95.8 |
9 /9 |
Angiotensin-converting enzyme 2 | |
8uze[2] | T |
EDO
1,2-ETHANEDIOL[4 atoms] |
B | 100.0 /95.8 |
2 /2 |
Angiotensin-converting enzyme 2 | |
8uze[1] | U |
EDO
1,2-ETHANEDIOL[4 atoms] |
B | 100.0 /95.8 |
3 /3 |
Angiotensin-converting enzyme 2 | |
8uzf[1] | N |
EDO
1,2-ETHANEDIOL[4 atoms] |
B | 100.0 /95.8 |
2 /2 |
Angiotensin-converting enzyme 2 | |
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue. |